E-LIB Suche - Ergebnisse für: Spiegel, Jay Y.

1

Engineered CD47 protects T cells for enhanced antitumour im..:

Yamada-Hunter, Sean A. ; Theruvath, Johanna ; McIntosh, Brianna J....
Nature. 630 (2024) 8016 - p. 457-465 , 2024

Link: https://doi.org/10.1038/..

2

CD22-directed CAR T-cell therapy for large B-cell lymphomas..:

Frank, Matthew J ; Baird, John H ; Kramer, Anne Marijn...
The Lancet. , 2024

Link: https://doi.org/10.1016/..

3

Bridging therapy with axicabtagene ciloleucel for large B-c..:

Jain, Michael D. ; Jacobs, Miriam T. ; Gao, Feng...
Blood Advances. 8 (2024) 4 - p. 1042-1050 , 2024

Link: https://doi.org/10.1182/..

4

Determinants of resistance to engineered T cell therapies t..:

Sworder, Brian J. ; Kurtz, David M. ; Alig, Stefan K....
Cancer Cell. 41 (2023) 1 - p. 210-225.e5 , 2023

Link: https://doi.org/10.1016/..

5

Severity of Cytokine Release Syndrome Influences Outcome Af..:

Jacobs, Miriam T. ; Jain, Michael D. ; Gao, Feng...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 10 - p. 753-759 , 2022

Link: https://doi.org/10.1016/..

6

Post-infusion CAR TReg cells identify patients resistant to..:

Good, Zinaida ; Spiegel, Jay Y. ; Sahaf, Bita...
Nature Medicine. 28 (2022) 9 - p. 1860-1871 , 2022

Link: https://doi.org/10.1038/..

7

CAR T cells with dual targeting of CD19 and CD22 in adult p..:

Spiegel, Jay Y. ; Patel, Shabnum ; Muffly, Lori...
Nature Medicine. 27 (2021) 8 - p. 1419-1431 , 2021

Link: https://doi.org/10.1038/..

8

Immune reconstitution and infectious complications followin..:

Baird, John H. ; Epstein, David J. ; Tamaresis, John S....
Blood Advances. 5 (2021) 1 - p. 143-155 , 2021

Link: https://doi.org/10.1182/..

9

Imagining the cell therapist: Future CAR T cell monitoring ..:

Jain, Michael D. ; Spiegel, Jay Y.
eJHaem. 3 (2021) S1 - p. 46-53 , 2021

Link: https://doi.org/10.1002/..

10

Concordance of peripheral blood and bone marrow measurable ..:

Muffly, Lori ; Sundaram, Vandana ; Chen, Connie...
Blood Advances. 5 (2021) 16 - p. 3147-3151 , 2021

Link: https://doi.org/10.1182/..

11

A phase I study of intravenous artesunate in patients with ..:

Deeken, John F. ; Wang, Hongkun ; Hartley, Marion...
Cancer Chemotherapy and Pharmacology. 81 (2018) 3 - p. 587-596 , 2018

Link: https://doi.org/10.1007/..

12

Impact of genomic alterations on outcomes in myelofibrosis ..:

Spiegel, Jay Y. ; McNamara, Caroline ; Kennedy, James A....
Blood Advances. 1 (2017) 20 - p. 1729-1738 , 2017

Link: https://doi.org/10.1182/..

13

Determinants of resistance to engineered T cell therapies t..:

Sworder, Brian J ; Kurtz, David M ; Alig, Stefan K.C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010070/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Treating CAR-T relapses: check not checkmate:

Spiegel, Jay Y ; Komanduri, Krishna V
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854681/. , 2022

Link: http://www.ncbi.nlm.nih...

15

CAR T cells with dual targeting of CD19 and CD22 in adult p..:

Spiegel, Jay Y ; Patel, Shabnum ; Muffly, Lori...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363505/. , 2021

Link: http://www.ncbi.nlm.nih...